The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Hikma Pharmaceuticals PLC HIK shares inched down 0.21% to £19.38 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.45 ...

Among patients with ischemic stroke treated with intravenous thrombolysis within 3 hours post-symptom onset, adjunctive treatment with intravenous argatroban or eptifibatide did not reduce ...

A pharmaceutical body has warned of potential shortages of some medicines in Northern Ireland unless there is a delay to the implementation of the Windsor Framework. The framework is the post ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.99% to £19.98 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0. ...

Telix Pharmaceuticals chief executive Christian Behrenbruch says the company could double sales in the next four years as its three new cancer treatment products hit the market and nuclear ...

Oct 16 (Reuters) - The U.S. Food and Drug Administration has put on hold a trial of Novavax's (NVAX.O), opens new tab COVID-influenza and its standalone flu vaccines after a participant who took ...

As stated above, Pharma 4.0 involves the implementation of technologies, such as AI, robotics, automation, and computational modeling, that enable the manufacturing of pharmaceutical products with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...